What does this research mean for the field?

Expression of the mutant (Arg92Gln) human cardiac troponin T impairs contractility in adult cardiac myocytes, providing a mechanism by which sarcomeric protein mutations cause hypertrophic cardiomyopathy. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The study aimed to determine how the Arg92Gln mutation in cardiac troponin T affects adult cardiac myocyte contractility.

July 1, 1997Circulation Research

Expression of a Mutant (Arg ⁹² Gln) Human Cardiac Troponin T, Known to Cause Hypertrophic Cardiomyopathy, Impairs Adult Cardiac Myocyte Contractility

View Full Paper

Ask AI

Bookmark

Why the study?

Does expression of mutant (Arg92Gln) human cardiac troponin T impair contractility in adult feline cardiac myocytes?

Key Points

The study aimed to determine how the Arg92Gln mutation in cardiac troponin T affects adult cardiac myocyte contractility.
Full-length human cardiac troponin T cDNA was cloned and mutated to Arg92Gln.
Recombinant adenoviruses were generated and used to infect adult feline cardiac myocytes at a high multiplicity of infection.
Western blots, immunocytochemistry, and electron microscopy were used to analyze protein expression and cell structure.
At 48 hours post-transduction, fractional shortening decreased by 24% (P < .001) and peak velocity of shortening decreased by 26% (P < .001).
At 72 hours, reductions in fractional shortening and peak velocity were 45% and 39%, respectively (P < .001).
Both normal and mutant cTnT were incorporated into myofibrils, showing structural integrity of sarcomeres.

Structured PICO

Does expression of mutant (Arg92Gln) human cardiac troponin T impair contractility in adult feline cardiac myocytes?

Population

Adult feline cardiac myocytes

Intervention

Expression of mutant (Arg92Gln) human cardiac troponin T (cTnT) via recombinant adenovirus Ad5/CMV/cTnT-Arg92Gln at a multiplicity of infection of 100

Comparator

Expression of normal human cTnT via Ad5/CMV/cTnT-N and a control viral vector (Ad5 delta E1)

Outcome

Cell fractional shortening and peak velocity of shortening at 24, 48, and 72 hours after transductionsurrogate

Expression of the HCM-causing mutant (Arg92Gln) human cardiac troponin T impairs contractility in adult cardiac myocytes, providing a potential mechanism for hypertrophic cardiomyopathy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Supports sarcomeric mutation hypothesis in feline model; leaves open clinical relevance for human HCM.

Cite This Study

Marian et al. (1997) studied this question.

synapsesocial.com/papers/6a1c45b6ea84844e355faba9 https://doi.org/10.1161/01.res.81.1.76

Topics

Hypertrophic cardiomyopathy

View Full Paper

Ask AI

Bookmark

Expression of a Mutant (Arg ⁹² Gln) Human Cardiac Troponin T, Known to Cause Hypertrophic Cardiomyopathy, Impairs Adult Cardiac Myocyte Contractility

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Expression of a Mutant (Arg ⁹² Gln) Human Cardiac Troponin T, Known to Cause Hypertrophic Cardiomyopathy, Impairs Adult Cardiac Myocyte Contractility

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider